UiPath Inc. (NYSE:PATH – Get Rating) CFO Ashim Gupta sold 10,000 shares of the business's stock in a transaction that occurred on Monday, December 5th. The stock was sold at an average price of $13.50, for a total transaction of $135,000.00. Following the completion of the transaction, the chief financial officer now owns 1,515,341 shares of the company's stock, valued at $20,457,103.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Ashim Gupta also recently made the following trade(s):

Get UiPath alerts:

• On Tuesday, November 1st, Ashim Gupta sold 10,000 shares of UiPath stock. The stock was sold at an average price of $12.48, for a total transaction of $124,800.00.
• On Monday, October 3rd, Ashim Gupta sold 10,000 shares of UiPath stock. The stock was sold at an average price of $12.69, for a total transaction of $126,900.00.
• On Monday, September 12th, Ashim Gupta sold 30,000 shares of UiPath stock. The shares were sold at an average price of $15.02, for a total transaction of $450,600.00.
• On Thursday, September 8th, Ashim Gupta sold 10,000 shares of UiPath stock. The shares were sold at an average price of $13.74, for a total transaction of $137,400.00.

UiPath Stock Up 4.3 %

Shares of UiPath stock opened at $13.10 on Friday. The company has a fifty day moving average of $12.28 and a 200 day moving average of $16.01. UiPath Inc. has a fifty-two week low of $10.40 and a fifty-two week high of $48.68.

UiPath (NYSE:PATH – Get Rating) last released its quarterly earnings data on Thursday, December 1st. The healthcare company reported ($0.09) EPS for the quarter, beating the consensus estimate of ($0.18) by $0.09. UiPath had a negative net margin of 34.99% and a negative return on equity of 17.19%. The business had revenue of $262.74 million during the quarter, compared to the consensus estimate of $248.07 million. On average, analysts anticipate that UiPath Inc. will post -0.55 earnings per share for the current year.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the stock. Credit Suisse Group decreased their target price on shares of UiPath from $30.00 to $27.50 and set an "outperform" rating for the company in a research note on Wednesday, November 16th. BMO Capital Markets decreased their target price on shares of UiPath from $21.00 to $15.00 in a research note on Wednesday, September 7th. Mizuho boosted their target price on shares of UiPath from $14.00 to $15.00 in a research note on Friday, December 2nd. Evercore ISI reduced their price objective on UiPath to $17.00 in a research note on Friday, December 2nd. Finally, Cowen reduced their price objective on UiPath from $27.00 to $20.00 in a research note on Wednesday, September 7th. Nine analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, UiPath presently has a consensus rating of "Hold" and a consensus price target of $22.23.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Prospera Financial Services Inc bought a new position in shares of UiPath during the 1st quarter valued at about $27,000. SeaCrest Wealth Management LLC bought a new position in shares of UiPath during the 2nd quarter valued at about $25,000. Banque Cantonale Vaudoise raised its position in shares of UiPath by 20,080.0% during the 2nd quarter. Banque Cantonale Vaudoise now owns 2,018 shares of the healthcare company's stock valued at $37,000 after buying an additional 2,008 shares in the last quarter. Householder Group Estate & Retirement Specialist LLC purchased a new stake in shares of UiPath during the 3rd quarter valued at about $25,000. Finally, CWM LLC purchased a new stake in shares of UiPath during the 2nd quarter valued at about $40,000. Institutional investors own 51.35% of the company's stock.

UiPath Company Profile

(Get Rating)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Recommended Stories

• Get a free copy of the StockNews.com research report on UiPath (PATH)
• Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
• This Is Why Daktronics Fell 40% In One Day
• Is It Time To Throw In The Towel On Gamestop?
• Why You Should Avoid Carvana Even if it Avoids Bankruptcy
• Are Investors Hearing The End Of Spotify's Downtrend?

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.